Inventor · disambiguated record
Yoshimasa Takahashi
Also filed as: TAKAHASHI YOSHIMASA
12 granted patents·8 pending applications·9 citations·filing 2004–2024
82Inventor score
Files withTEIJIN PHARMA LTD6JAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NAT INSTITUTE OF INFECTIOUS DISEASES5SHIRAKURA TAKASHI2YAMANA KEI2DENKA COMPANY LTD1
Top patents by PatentIndex Score
20 records- 0184US12059462B2Composition containing influenza vaccineJAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NAT INSTITUTE OF INFECTIOUS DISEASES·Filed 2019·Granted Aug 13, 2024·4 cites·19 claims
- 0280US11732031B2Method for producing influenza HA split vaccineJAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NAT INSTITUTE OF INFECTIOUS DISEASES·Filed 2019·Granted Aug 22, 2023·3 cites·28 claims
- 0370US2025009869A1Composition containing influenza vaccineJAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NAT INSTITUTE OF INFECTIOUS DISEASES·Filed 2024·Application pending·0 cites
- 0467US9388174B2Azole benzene derivativeTEIJIN PHARMA LTD·Filed 2014·Granted Jul 12, 2016·2 cites·16 claims
- 0559US2023406910A1Method for producing influenza ha split vaccineJAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NAT INSTITUTE OF INFECTIOUS DISEASES·Filed 2023·Application pending·0 cites
- 0654US2023348573A1Sars-cov-2 neutralizing antibody or fragment thereofUNIV KEIO·Filed 2021·Application pending·0 cites
- 0749US12491240B2Method for producing influenza HA split vaccineJAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NAT INSTITUTE OF INFECTIOUS DISEASES·Filed 2020·Granted Dec 9, 2025·0 cites·22 claims
- 0848US2024287161A1Antibody against coronavirusNAT UNIV CORP TOTTORI UNIV·Filed 2021·Application pending·0 cites
- 0946US10301300B2Xanthine oxidase inhibitorTEIJIN LTD·Filed 2018·Granted May 28, 2019·0 cites·15 claims
- 1046US8617841B2Protein and production process and use thereofYAMANA KEI·Filed 2004·Granted Dec 31, 2013·0 cites·10 claims
- 1145US9637469B2Pyridine derivativeTEIJIN PHARMA LTD·Filed 2013·Granted May 2, 2017·0 cites·10 claims
- 1244US8481676B2Protein and production process and use thereofYAMANA KEI·Filed 2009·Granted Jul 9, 2013·0 cites·2 claims
- 1339US2017190694A1Pyridine derivativeTEIJIN PHARMA LTD·Filed 2017·Application pending·0 cites
- 1438US9617240B2Pyrazole derivativeTEIJIN PHARMA LTD·Filed 2014·Granted Apr 11, 2017·0 cites·19 claims
- 1537US2018179256A1Modified H7 Hemagglutinin Glycoprotein of the Influenza A/Shanghai/2/2013 H7 SequenceEPIVAX INC·Filed 2016·Application pending·0 cites
- 1636US2017217948A1Xanthine oxidase inhibitorTEIJIN PHARMA LTD·Filed 2015·Application pending·0 cites
- 1732US11517616B2Composite polypeptide monomer, aggregate of said composite polypeptide monomer having cell penetration function, and norovirus component vaccine for subcutaneous, intradermal, percutaneous, or intramuscular administration and having said aggregate as effective component thereofDENKA COMPANY LTD·Filed 2017·Granted Dec 6, 2022·0 cites·8 claims
- 1831US9856237B2Pyrazine derivativesTEIJIN PHARMA LTD·Filed 2015·Granted Jan 2, 2018·0 cites·18 claims
- 1920US9545445B2Therapeutic drug for hypertension or prehypertensionSHIRAKURA TAKASHI·Filed 2010·Granted Jan 17, 2017·0 cites·4 claims
- 2019US2013109726A1Sustained-release therapeutic agent for hypertension and renal dysfunctionSHIRAKURA TAKASHI·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yoshimasa Takahashi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →